Showing results (1761-1770 of 2,381) with videos related to
Sort By:
Pageof 239
Current Opinion in Pharmacology|July 2, 2016
Towards antiviral therapies for treating dengue virus infectionsSuzanne Jf Kaptein, Johan NeytsCurrent Opinion in Pharmacology|October 11, 2008
Annexin A1 and the formyl peptide receptor family: neuroendocrine and metabolic aspectsChristopher D John, Felicity N E Gavins, Nicholas A P S Buss, et al.Current Opinion in Pharmacology|August 12, 2026
Pharmacological targeting of neuroimmune-synaptic interactions in Alzheimer's disease: Integrating NETosis, microglia, and synaptic vulnerabilityChen Juanlu, Li-Han ChenCurrent Opinion in Pharmacology|September 1, 2026
Piezo1 and Piezo2 in neurological disorders: From mechanotransduction to therapeutic potentialLu Zhao, Chao Wang, Yudan Zhu, et al.Current Opinion in Pharmacology|August 27, 2026
Mitochondria as a therapeutic platform in inflammatory and degenerative disorders: mechanisms, biomarkers, and translational challengesLamiaa M ElAbbasyCurrent Opinion in Pharmacology|September 22, 2022
Metabokines in the regulation of systemic energy metabolismAmanda Dv MacCannell, Lee D RobertsCurrent Opinion in Pharmacology|November 5, 2022
The emerging role of immunotherapy in the treatment of anal cancerRita Saúde-Conde, Alessandro Parisi, Emilio Francesco Giunta, et al.Current Opinion in Pharmacology|November 6, 2022
Reprogramming cell fates towards novel cancer immunotherapiesEva Hin Wa Leung, Kenneth Joves, Aydolun Petenkaya, et al.Current Opinion in Pharmacology|October 12, 2022
Routine neoadjuvant chemotherapy for all patients with resectable pancreatic ductal adenocarcinoma? A review of the evidenceZachary J Brown, Samantha M Ruff, Jordan M CloydCurrent Opinion in Pharmacology|December 10, 2014
Metabotropic glutamate receptor 5 as drug target for Fragile X syndromeSebastian H Scharf, Georg Jaeschke, Joseph G Wettstein, et al.Pageof 239